scholarly journals Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma

2015 ◽  
Vol 5 (2) ◽  
pp. 192-199 ◽  
Author(s):  
Daniel M. Geynisman ◽  
Elizabeth Handorf ◽  
Yu‐Ning Wong ◽  
Jamie Doyle ◽  
Elizabeth R. Plimack ◽  
...  
Keyword(s):  
Urothelial Carcinoma ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Clinical Characteristics ◽  
Treatment Patterns ◽  
Small Cell ◽  
Carcinoma Of The Bladder

Locoregional Small Cell Carcinoma of the Bladder: Clinical Characteristics and Treatment Patterns

2014 ◽  
Vol 191 (2) ◽  
pp. 329-334 ◽  
Author(s):  
Sanjay G. Patel ◽  
C.J. Stimson ◽  
Harras B. Zaid ◽  
Matthew J. Resnick ◽  
Michael S. Cookson ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Clinical Characteristics ◽  
Treatment Patterns ◽  
Small Cell ◽  
Carcinoma Of The Bladder

1878 SMALL CELL CARCINOMA OF THE BLADDER: CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Sanjay G. Patel ◽  
C.J. Stimson ◽  
Harras B. Zaid ◽  
Daniel A. Barocas ◽  
Matthew J. Resnick ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Clinical Characteristics ◽  
Treatment Patterns ◽  
Small Cell ◽  
Carcinoma Of The Bladder

scholarly journals A Case of Primary Small-Cell Carcinoma of the Bladder

2016 ◽  
Vol 9 (3) ◽  
pp. 574-579 ◽  
Author(s):  
Ashita Ono ◽  
Yosuke Hirasawa ◽  
Mitsumasa Yamashina ◽  
Naoto Kaburagi ◽  
Takashi Mima ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Urothelial Carcinoma ◽  
Cell Carcinoma ◽  
Radical Cystectomy ◽  
Small Cell Carcinoma ◽  
Distant Metastasis ◽  
Small Cell ◽  
Common Type ◽  
Cell Of Origin ◽  
Carcinoma Of The Bladder

Primary small-cell carcinoma arising from the bladder (SmCCB) is uncommon. It differs from urothelial carcinoma (UC), the most common type of bladder cancer, with respect to its cell of origin, biology, and prognosis. Biologically, prostatic SmCCB is much more aggressive than UC, and the prognosis for cases with distant metastasis is especially poor. We report here a case of primary SmCCB (cT3bN1M0) treated with radical cystectomy.

Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder

2018 ◽  
Vol 4 (6) ◽  
pp. 900-906 ◽  
Author(s):  
Benjamin W. Fischer-Valuck ◽  
Yuan James Rao ◽  
Lauren E. Henke ◽  
Soumon Rudra ◽  
Caressa Hui ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Treatment Patterns ◽  
Small Cell ◽  
Survival Outcomes ◽  
Carcinoma Of The Bladder

Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder

2015 ◽  
Vol 94 (4) ◽  
pp. 401-405 ◽  
Author(s):  
Jairam R. Eswara ◽  
Niall M. Heney ◽  
Chin-Lee Wu ◽  
W. Scott McDougal
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Metastatic Disease ◽  
Advanced Disease ◽  
Chemical Exposure ◽  
Small Cell ◽  
Cancer Specific Survival ◽  
Entire Cohort ◽  
Aggressive Disease ◽  
Carcinoma Of The Bladder

Background: Small cell carcinoma of the bladder is an uncommon but clinically aggressive disease. There is no standard surgical or medical management for the disease. Methods: Between 1995 and 2009, 28 patients underwent transurethral resection (TUR) and/or cystectomy, chemotherapy, and/or radiation for small cell carcinoma of the bladder at our institution. Results: The median follow-up for survivors was 34 months. Patients presented most often with muscle-invasive disease (T2-4 - 89%), and 21% had lymph node/distant metastases. Tobacco use and chemical exposure were noted in 64 and 4% of patients, respectively. Patients with T1-2N0M0 had a median survival of 22 months compared to 8 months for those with more advanced disease (p = 0.03). Patients with T3-4 or nodal/metastatic disease who were given chemotherapy had an improved survival compared to those with T3-4 or nodal/metastatic disease who did not undergo chemotherapy (13 vs. 4 months, p = 0.005). The median time to recurrence of the entire cohort was 8 months, overall and cancer-specific survival was 14 months, and 5-year survival was 11%. Conclusions: Small cell carcinoma of the bladder is an aggressive disease with poor outcomes. Patients with T1-2N0M0 disease survived longer than those with advanced disease. Patients with T3-4 or nodal/metastatic disease had improved survival with chemotherapy.

SMALL CELL CARCINOMA OF THE BLADDER MIMICKING A GYNECOLOGICAL TUMOR

2001 ◽  
Vol 165 (1) ◽  
pp. 186-187 ◽  
Author(s):  
LI-JEN WANG ◽  
YON-CHEONG WONG ◽  
YANG-JEN CHIANG ◽  
CHI-JEN CHEN
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Small Cell ◽  
Gynecological Tumor ◽  
Carcinoma Of The Bladder

scholarly journals (P027) Evaluating Treatment Patterns for Small Cell Carcinoma of the Colon Using the National Cancer Database

2017 ◽  
Vol 98 (2) ◽  
pp. E22
Author(s):  
Sadhana Balasubramanyam ◽  
Barrett P. O'Donnell ◽  
Michelle S. Ludwig ◽  
Benjamin L. Musher ◽  
Pavan M. Jhaveri
Keyword(s):  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Treatment Patterns ◽  
Small Cell ◽  
National Cancer Database ◽  
Carcinoma Of The Colon
Sign in / Sign up

Export Citation Format

Share Document